Top AMEX Stock Movers (PIP, GMO, KEM)

PharmAthene, Inc. (AMEX:PIP) plunged 14% to $3.51 on unusual volumes. The company announced that it has priced a registered public offering of 4,300,000 shares of its common stock at a price to the public of $3.50 per share. In connection with the offering, the Company also granted the underwriter a 30-day option to purchase up to an additional 645,000 shares to cover over-allotments, if any. The offering is expected to close on or about November 3, 2010. The stock traded within the range of $3.50-$3.63. At closing market price, the market capitalization of the company stands at $115.02 million. General Moly, Inc. (AMEX:GMO) soared 20.93% to close at $5.20 after it made its fresh 52-week high of $5.24. The company said it has a net loss of $6.3 million or $0.09 per share in its third quarter. Consolidated cash balance at the end of the third quarter was approximately $17 million compared to approximately $23 million at the end of the second quarter and approximately $49 million at the end of 2009. The stock went up more than 150% year-to-date. The 52-week range of the stock is $1.85-$5.24. KEMET Corporation (AMEX:KEM) jumped 10.95% to $3.75. The Company posted second quarter 2011 results. The company reported that its net income jumped to $34.3 million or $0.42 a basic share from $0.22 a share a year ago period. Revenue grew 43.5% to $248.6 million from $243.8 million in a year ago quarter. The stock opened at $3.37 and traded within the range of $3.37-$3.83. Over the past five trading sessions, the stock went up more than 25%. Disclaimer: The assembled information distributed by epicstockpicks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Epicstockpicks.com does expect that investors will buy and sell securities based on information assembled and presented herein. EpicStockPicks.com will not be responsible in any way for or accept any liability for any losses arising from an investor's reliance on or use of information obtained from our website or emails. PLEASE always do your own due diligence, and consult your financial advisor.
tdp2664
Epic Stock Picks